Pancreatic cancer is known for its low survival rates and limited treatment options. Fortunately, it is now showing signs of potential improvement with the use of messenger RNA vaccines.
RNA vaccines are known for their effectiveness against COVID-19. They have demonstrated promising results in a recent trial targeting pancreatic cancer.
In the study, half of the 16 patients who received mRNA cancer vaccines did not experience tumor recurrence after a year and a half. However, further research involving larger studies is necessary to confirm these findings.
Pancreatic cancer has alarmingly high mortality rates. It …

A new variant of the COVID virus, named Arcturus, has attracted global attention. This is because of its rapid transmission as well as the unexpected symptom it causes.
It was initially detected in India but has rapidly spread to numerous countries. The World Health Organization has classified Arcturus as a variant of interest. It is associated with genetic changes and competitive advantage over other circulating variants.
Arcturus is associated with red and irritated eyes. Although the presence of pink eye may appear alarming, experts say viral conjunctivitis is not a major concern by itself. They also claim Arcturus does …